Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Selecta
480 Arsenal St., Building One
Watertown, MA 02472
Phone: 617-923-1400
http://www.selecta.com/

Selecta Biosciences, Inc. is a clinical-stage biotechnology company developing novel drugs that use immune modulating nanomedicines to generate targeted antigen-specific immune responses to prevent and treat disease. Selecta's proprietary Synthetic Vaccine Particle (SVP) platform creates a novel paradigm in immunotherapeutics and vaccines, enabling completely new applications while offering the potential of improved efficacy and safety profiles.

Key Contact
NameTitleE-Mail
Werner CautreelsCEO


Funding Events
DateAmountTypeInvestors
10/15/14$20,000,000 Eminent Venture Capital
Flagship Ventures
I2BF Global Ventures
Leukon Investments
NanoDimension
OrbiMed Advisors
Polaris Venture Partners
RUSNANO
09/08/15$38,000,000Series E AJU IB Investment
Eminent Venture Capital
Flagship Ventures
I2BF Global Ventures
Leukon Investments
NanoDimension
OrbiMed Advisors
Osage University Partners
Polaris Venture Partners
Ridgeback Capital Management
Sanofi-Genzyme BioVentures
Sphera Global Healthcare
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.